← Browse by Condition
Medical Condition
age related macular degeneration armd
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1
NCT07330674 Phase 1
Recruiting
A Phase 1 Study of ABF-101 in Single- and Multiple-Ascending Doses
Enrollment
68 pts
Location
United States
Sponsor
Aptabio Therapeutics, Inc.
NCT06662162
Recruiting
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
Enrollment
100 pts
Location
Australia, New Zeala...
Sponsor
i-Lumen Scientific AUS PTY LTD